http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872142-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be67a8a80230cdd4b76514f81e83a79c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ca1f1bd52ea522193c62342978e43c3 |
| publicationDate | 2013-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102872142-A |
| titleOfInvention | The application of Houttuynoid D in the treatment of ovarian cancer |
| abstract | The invention discloses the application of Houttuynoid D in the preparation of medicines for treating human ovarian cancer, and belongs to the technical field of new uses of medicines. The present invention finds through MTT anti-tumor activity evaluation in vitro that HouttuynoidD also has significant inhibitory effect on the growth of human ovarian cancer cell lines HO-8910, HOC1 and OVAC. Therefore, HouttuynoidD can be used to prepare anti-ovarian cancer drugs, and has good development and application prospects. The use of HouttuynoidD involved in the present invention in the preparation of drugs for the treatment of human ovarian cancer is disclosed for the first time, because the skeleton type is a new skeleton type, and its inhibitory activity against human ovarian cancer cells is unexpectedly strong. |
| priorityDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467782779 |
Total number of triples: 15.